[1] V.S. Pelly, A. Moeini, L.M. Roelofsen, E. Bonavita, C.R. Bell, C. Hutton, A. Blanco-Gomez, A. Banyard, C.P. Bromley, E. Flanagan, S.-C. Chiang, C. Jorgensen, T.N. Schumacher, D.S. Thommen, S. Zelenay, Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy, Cancer Discov, (2021).
[2] D. Grennan, S. Wang, Steroid Side Effects, JAMA, 322 (2019) 282.
[3] P. Chotiyarnwong, E.V. McCloskey, Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment, Nat Rev Endocrinol, 16 (2020) 437-447.
[4] J.E. Compston, M.R. McClung, W.D. Leslie, Osteoporosis, Lancet, 393 (2019) 364-376.
[5] L. Song, L. Cao, R. Liu, H. Ma, Y. Li, Q. Shang, Z. Zheng, L. Zhang, W. Zhang, Y. Han, X. Zhang, H. Yang, Y. Wang, G. Melino, C. Shao, Y. Shi, The critical role of T cells in glucocorticoid-induced osteoporosis, Cell Death Dis, 12 (2020) 45.
[6] L. Buckley, M.B. Humphrey, Glucocorticoid-Induced Osteoporosis, N Engl J Med, 379 (2018) 2547-2556.
[7] J.P. Bidwell, M.B. Alvarez, M. Hood, P. Childress, Functional impairment of bone formation in the pathogenesis of osteoporosis: the bone marrow regenerative competence, Curr Osteoporos Rep, 11 (2013) 117-125.
[8] F. Zhang, W. Peng, J. Zhang, W. Dong, J. Wu, T. Wang, Z. Xie, P53 and Parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head, Cell Death Dis, 11 (2020) 42.
[9] S. Doll, F.P. Freitas, R. Shah, M. Aldrovandi, M.C. da Silva, I. Ingold, A. Goya Grocin, T.N. Xavier da Silva, E. Panzilius, C.H. Scheel, A. Mourão, K. Buday, M. Sato, J. Wanninger, T. Vignane, V. Mohana, M. Rehberg, A. Flatley, A. Schepers, A. Kurz, D. White, M. Sauer, M. Sattler, E.W. Tate, W. Schmitz, A. Schulze, V. O'Donnell, B. Proneth, G.M. Popowicz, D.A. Pratt, J.P.F. Angeli, M. Conrad, FSP1 is a glutathione-independent ferroptosis suppressor, Nature, 575 (2019) 693-698.
[10] C. Mao, X. Liu, Y. Zhang, G. Lei, Y. Yan, H. Lee, P. Koppula, S. Wu, L. Zhuang, B. Fang, M.V. Poyurovsky, K. Olszewski, B. Gan, DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer, Nature, 593 (2021) 586-590.
[11] J. Zheng, M. Conrad, The Metabolic Underpinnings of Ferroptosis, Cell Metab, 32 (2020) 920-937.
[12] X. Jiang, B.R. Stockwell, M. Conrad, Ferroptosis: mechanisms, biology and role in disease, Nat Rev Mol Cell Biol, 22 (2021) 266-282.
[13] J. Lu, J. Yang, Y. Zheng, X. Chen, S. Fang, Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence, Sci Rep, 9 (2019) 16130.
[14] A. Slomski, Melatonin Improves Sleep in Patients With Circadian Disruption, JAMA, 320 (2018) 749.
[15] A. Karamitri, R. Jockers, Melatonin in type 2 diabetes mellitus and obesity, Nat Rev Endocrinol, 15 (2019) 105-125.
[16] S. Tousi, P. Zoufan, A.R. Ghahfarrokhie, Alleviation of cadmium-induced phytotoxicity and growth improvement by exogenous melatonin pretreatment in mallow (Malva parviflora) plants, Ecotoxicol Environ Saf, 206 (2020) 111403.
[17] E. Motallebzadeh, A.A. Tameh, S.A.T. Zavareh, B. Farhood, A. Aliasgharzedeh, M. Mohseni, Neuroprotective effect of melatonin on radiation-induced oxidative stress and apoptosis in the brainstem of rats, J Cell Physiol, 235 (2020) 8791-8798.
[18] S. Rastogi, C. Haldar, Comparative effect of melatonin and quercetin in counteracting LPS induced oxidative stress in bone marrow mononuclear cells and spleen of Funambulus pennanti, Food Chem Toxicol, 120 (2018) 243-252.
[19] D.S. Salmanoglu, T. Gurpinar, K. Vural, N. Ekerbicer, E. Darıverenli, A. Var, Melatonin and L-carnitin improves endothelial disfunction and oxidative stress in Type 2 diabetic rats, Redox Biol, 8 (2016) 199-204.
[20] L.d.S. Borges, A. Dermargos, E.P. da Silva Junior, E. Weimann, R.H. Lambertucci, E. Hatanaka, Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis, J Pineal Res, 58 (2015) 166-172.
[21] H. Ma, X. Wang, W. Zhang, H. Li, W. Zhao, J. Sun, M. Yang, Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis, Oxid Med Cell Longev, 2020 (2020) 9067610.
[22] A.M. Greenbaum, L.D. Revollo, J.R. Woloszynek, R. Civitelli, D.C. Link, N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells, Blood, 120 (2012) 295-302.
[23] B.S. Moriarity, G.M. Otto, E.P. Rahrmann, S.K. Rathe, N.K. Wolf, M.T. Weg, L.A. Manlove, R.S. LaRue, N.A. Temiz, S.D. Molyneux, K. Choi, K.J. Holly, A.L. Sarver, M.C. Scott, C.L. Forster, J.F. Modiano, C. Khanna, S.M. Hewitt, R. Khokha, Y. Yang, R. Gorlick, M.A. Dyer, D.A. Largaespada, A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis, Nat Genet, 47 (2015) 615-624.
[24] X. Liu, M. Chen, J. Luo, H. Zhao, X. Zhou, Q. Gu, H. Yang, X. Zhu, W. Cui, Q. Shi, Immunopolarization-regulated 3D printed-electrospun fibrous scaffolds for bone regeneration, Biomaterials, 276 (2021) 121037.
[25] W. Fu, W. Hu, Y.-S. Yi, A. Hettinghouse, G. Sun, Y. Bi, W. He, L. Zhang, G. Gao, J. Liu, K. Toyo-Oka, G. Xiao, D.B. Solit, P. Loke, C.-J. Liu, TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity, J Clin Invest, (2021).
[26] C. Dou, J. Li, J. He, F. Luo, T. Yu, Q. Dai, Y. Chen, J. Xu, X. Yang, S. Dong, Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis, Bioact Mater, 6 (2021) 4697-4706.
[27] T. Vellai, How the amino acid leucine activates the key cell-growth regulator mTOR, Nature, (2021).
[28] A. Cipponi, D.L. Goode, J. Bedo, M.J. McCabe, M. Pajic, D.R. Croucher, A.G. Rajal, S.R. Junankar, D.N. Saunders, P. Lobachevsky, A.T. Papenfuss, D. Nessem, M. Nobis, S.C. Warren, P. Timpson, M. Cowley, A.C. Vargas, M.R. Qiu, D.G. Generali, S. Keerthikumar, U. Nguyen, N.M. Corcoran, G.V. Long, J.-Y. Blay, D.M. Thomas, MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer, Science, 368 (2020) 1127-1131.
[29] L. Xian, X. Wu, L. Pang, M. Lou, C.J. Rosen, T. Qiu, J. Crane, F. Frassica, L. Zhang, J.P. Rodriguez, J. Xiaofeng, Y. Shoshana, X. Shouhong, E. Argiris, W. Mei, C. Xu, Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells, Nat Med, 18 (2012) 1095-1101.
[30] J. Yan, B. Ni, G. Sheng, Y. Zhang, Y. Xiao, Y. Ma, H. Li, H. Wu, C. Tu, Rhoifolin Ameliorates Osteoarthritis Regulating Autophagy, Front Pharmacol, 12 (2021) 661072.
[31] B. Stauch, L.C. Johansson, J.D. McCorvy, N. Patel, G.W. Han, X.-P. Huang, C. Gati, A. Batyuk, S.T. Slocum, A. Ishchenko, W. Brehm, T.A. White, N. Michaelian, C. Madsen, L. Zhu, T.D. Grant, J.M. Grandner, A. Shiriaeva, R.H.J. Olsen, A.R. Tribo, S. Yous, R.C. Stevens, U. Weierstall, V. Katritch, B.L. Roth, W. Liu, V. Cherezov, Structural basis of ligand recognition at the human MT melatonin receptor, Nature, 569 (2019) 284-288.
[32] T. Rui, H. Wang, Q. Li, Y. Cheng, Y. Gao, X. Fang, X. Ma, G. Chen, C. Gao, Z. Gu, S. Song, J. Zhang, C. Wang, Z. Wang, T. Wang, M. Zhang, J. Min, X. Chen, L. Tao, F. Wang, C. Luo, Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury-induced ferroptosis, J Pineal Res, 70 (2021) e12704.
[33] Z. Gou, X. Su, X. Hu, Y. Zhou, L. Huang, Y. Fan, J. Li, L. Lu, Melatonin improves hypoxic-ischemic brain damage through the Akt/Nrf2/Gpx4 signaling pathway, Brain Res Bull, 163 (2020) 40-48.
[34] G. Adami, K.G. Saag, Glucocorticoid-induced osteoporosis: 2019 concise clinical review, Osteoporos Int, 30 (2019) 1145-1156.
[35] G. Shen, H. Ren, Q. Shang, T. Qiu, X. Yu, Z. Zhang, J. Huang, W. Zhao, Y. Zhang, D. Liang, X. Jiang, Autophagy as a target for glucocorticoid-induced osteoporosis therapy, Cell Mol Life Sci, 75 (2018) 2683-2693.
[36] R. Rizzoli, E. Biver, Glucocorticoid-induced osteoporosis: who to treat with what agent?, Nat Rev Rheumatol, 11 (2015).
[37] Q. Xing, J. Feng, X. Zhang, Semaphorin3B Promotes Proliferation and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in a High-Glucose Microenvironment, Stem Cells Int, 2021 (2021) 6637176.
[38] G.-Y. Shen, H. Ren, Q. Shang, W.-H. Zhao, Z.-D. Zhang, X. Yu, J.-J. Huang, J.-J. Tang, Z.-D. Yang, D. Liang, X.-B. Jiang, Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss, Int J Biol Sci, 15 (2019) 2182-2197.
[39] J. Li, N. Zhang, X. Huang, J. Xu, J.C. Fernandes, K. Dai, X. Zhang, Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation, Cell Death Dis, 4 (2013) e832.
[40] N. Yang, H. Sun, Y. Xue, W. Zhang, H. Wang, H. Tao, X. Liang, M. Li, Y. Xu, L. Chen, L. Zhang, L. Huang, D. Geng, Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head, Clin Transl Med, 11 (2021) e447.
[41] Y. Mo, W. Lai, Y. Zhong, Z. Hu, M. You, M. Du, P. Wang, X. Wu, C. Chen, H. He, Z. Gao, Y. Xu, D. Wang, L. Cui, Y. Yang, TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis, Life Sci, 266 (2021) 118938.
[42] S.K. NaveenKumar, M. Hemshekhar, K. Kemparaju, K.S. Girish, Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin, Biochim Biophys Acta Mol Basis Dis, 1865 (2019) 2303-2316.
[43] P.M. LoRusso, Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors, J Clin Oncol, 34 (2016) 3803-3815.
[44] D.A. Fruman, C. Rommel, PI3K and cancer: lessons, challenges and opportunities, Nat Rev Drug Discov, 13 (2014) 140-156.
[45] J. Yi, J. Zhu, J. Wu, C.B. Thompson, X. Jiang, Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis, Proc Natl Acad Sci U S A, 117 (2020) 31189-31197.
[46] R. Zhao, L. Tao, S. Qiu, L. Shen, Y. Tian, Z. Gong, Z.B. Tao, Y. Zhu, Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways, Life Sci, 257 (2020) 118044.
[47] M. Chen, E. Cecon, A. Karamitri, W. Gao, R. Gerbier, R. Ahmad, R. Jockers, Melatonin MT and MT receptor ERK signaling is differentially dependent on G and G proteins, J Pineal Res, 68 (2020) e12641.
[48] B. Tang, J. Zhu, S. Fang, Y. Wang, R. Vinothkumar, M. Li, Q. Weng, L. Zheng, Y. Yang, R. Qiu, M. Xu, Z. Zhao, J. Ji, Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis, Free Radic Biol Med, 172 (2021) 312-329.